Catalyst wins reversal in orphan exclusivity court battle with FDA
A US appeals court on Thursday afternoon overturned a prior FDA court win, saying that the agency never should’ve approved a rare disease drug because …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
